Home / Stocks / CRL

Charles River Laboratories International (CRL, Life Sciences Tools & Services) Stock Valuation & Fair Value Significantly overvalued

Charles River Laboratories International (CRL, Life Sciences Tools & Services) trades at a blended P/E of 26.6, about 38% above its historical normal valuation, with a forward growth estimate of 11.7% and a PEG of 2.28. Analysts' one-year estimates have been hit 91% of the time.

DATA AS OF 2026-08-21
Blended P/E
26.6
Normal P/E
19.3
PEG
2.28
Fwd growth
11.7%
Div yield
0.0%
RSI (14)
70.3
Overbought

The Street vs SeerForecast

Wall Street's mean price target for CRL is $281.00 across 14 analysts, 4.8% below the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: significantly overvalued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from fairly valued (2026-06-03) to significantly overvalued (2026-08-21).

Price and rating by weekClose moved +55.7 percent from 2026-06-03 to 2026-08-17, with 2 rating changes over 21 recorded weeks.2026-06-03: Fairly valued, close 179.87 (recalculated)2026-06-10: Fairly valued, close 186.29 (recalculated)2026-06-14: Fairly valued, close 187.51 (recalculated)2026-06-16: Fairly valued, close 184.79 (recalculated)2026-06-21: Fairly valued, close 185.00 (recalculated)2026-07-02: Trading above fair value, close 230.69 (recalculated)2026-07-06: Trading above fair value, close 231.43 (recalculated)2026-07-09: Trading above fair value, close 233.60 (recalculated)2026-07-12: Trading above fair value, close 233.41 (recalculated)2026-07-13: Trading above fair value, close 229.75 (recalculated)2026-07-14: Trading above fair value, close 231.21 (recalculated)2026-07-20: Trading above fair value, close 219.70 (recalculated)2026-07-22: Trading above fair value, close 218.70 (recalculated)2026-07-25: Trading above fair value, close 226.58 (recalculated)2026-07-27: Trading above fair value, close 224.30 (recalculated)2026-07-31: Trading above fair value, close 232.51 (recalculated)2026-08-03: Trading above fair value, close 232.512026-08-07: Trading above fair value, close 267.49 (recalculated)2026-08-10: Trading above fair value, close 267.492026-08-14: Significantly overvalued, close 280.05 (recalculated)2026-08-17: Significantly overvalued, close 280.051802802026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 17.1-11%Fairly valued
2026-06-10P/E 17.1-11%Fairly valued
2026-06-14P/E 17.1-11%Fairly valued
2026-06-16P/E 17.1-11%Fairly valued
2026-06-21P/E 17.1-11%Fairly valued
2026-07-02P/E 21.4+11%Trading above fair value
2026-07-06P/E 21.6+12%Trading above fair value
2026-07-09P/E 21.6+12%Trading above fair value
2026-07-12P/E 21.8+13%Trading above fair value
2026-07-13P/E 21.8+13%Trading above fair value
2026-07-14P/E 21.8+13%Trading above fair value
2026-07-20P/E 20.9+9%Trading above fair value
2026-07-22P/E 20.9+9%Trading above fair value
2026-07-25P/E 21.1+9%Trading above fair value
2026-07-27P/E 21.1+9%Trading above fair value
2026-07-31P/E 21.8+13%Trading above fair value
2026-08-03P/E 21.6+12%Trading above fair value
2026-08-07P/E 24.4+26%Trading above fair value
2026-08-10P/E 24.5+27%Trading above fair value
2026-08-14P/E 25.7+33%Significantly overvalued
2026-08-17P/E 25.6+33%Significantly overvalued
2026-08-21P/E 26.6+38%Significantly overvalued ← now

Frequently asked questions

Is Charles River Laboratories International stock overvalued?

At a blended P/E of 26.6 versus its historical normal P/E of 19.3, Charles River Laboratories International trades about 38% above its typical valuation, with a PEG of 2.28 on 11.7% forward growth. tickerseer currently rates it significantly overvalued.

What is Charles River Laboratories International's fair value and PEG?

Charles River Laboratories International trades at a blended P/E of 26.6 against a historical normal P/E of 19.3, a PEG of 2.28, and a forward growth estimate of 11.7%.

Has tickerseer's rating of Charles River Laboratories International changed?

tickerseer's rating moved from fairly valued (2026-06-03) to significantly overvalued (2026-08-21).

What is the analyst price target for Charles River Laboratories International?

The mean Wall Street price target for Charles River Laboratories International is $281.00 across 14 analysts, 4.8% below the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Life Sciences Tools & Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track CRL free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.